Jaguar Health (JAGX) Land & Improvements (2017 - 2018)
Jaguar Health's (JAGX) quarterly Land & Improvements came in at $396247.0 in Q1 2018, little changed on a QoQ basis from $396247.0 in Q4 2017.
Jaguar Health (JAGX) Land & Improvements (2017 - 2018) Analysis & Trends
Jaguar Health (JAGX) has 2 years of Land & Improvements data on file, last reported at $396247.0 in Q1 2018.
- On a quarterly basis, Land & Improvements changed N/A year-over-year to $396247.0 in Q1 2018; TTM through Mar 2018 was $396247.0, a N/A change from a year earlier, with the FY2017 full-year figure at $396247.0, changed N/A from the prior year.
- Land & Improvements for Q1 2018 stood at $396247.0, roughly flat from $396247.0 in the prior quarter.
- Over the last five years, Land & Improvements for JAGX reached as high as $396247.0 in Q4 2017 and fell as low as $396247.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | - |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | - |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | - |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | - |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 396,247.00 |
| Dec 31, 2017 | 396,247.00 |